GEHC: Pangali EV/EBITDA GE HealthCare Technologies

GE HealthCare leads the imaging sector through the integration of AI into diagnostics. The synergy between smart systems and a massive order backlog determines the current valuation based on the EV/EBITDA multiple, where 12.53 is recorded as the baseline value. However, component inflation, currency risks, and a potential stagnation in healthcare facility capital expenditures are weighing on the share price.

GE HealthCare maintains stability by scaling AI solutions that mitigate the impact of high equipment costs on margins. By analyzing the company's current EV/EBITDA multiple on GURU.Markets, an investor assesses the business value relative to its operating profit before depreciation and interest. The trend of this ratio filters out market noise, revealing the actual macroeconomic sensitivity of the assets. A decline in this metric signals that the business is undervalued while maintaining potential for operating leverage.